Patents by Inventor Mark Cronin

Mark Cronin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of activin receptor-like kinase
    Patent number: 12595265
    Abstract: Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.
    Type: Grant
    Filed: April 20, 2023
    Date of Patent: April 7, 2026
    Assignee: Blueprint Medicines Corporation
    Inventors: Natasja Brooijmans, Jason D. Brubaker, Paul E. Fleming, Brian Lewis Hodous, Joseph L. Kim, Brett D. Williams, Douglas Wilson, Kevin J. Wilson, Mark Cronin
  • INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
    Publication number: 20240158398
    Abstract: Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.
    Type: Application
    Filed: April 20, 2023
    Publication date: May 16, 2024
    Inventors: Natasja Brooijmans, Jason D. Brubaker, Paul E. Fleming, Brian Lewis Hodous, Joseph L. Kim, Brett D. Williams, Douglas Wilson, Kevin J. Wilson, Mark Cronin
  • Inhibitors of activin receptor-like kinase
    Patent number: 11634422
    Abstract: Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: April 25, 2023
    Assignee: Blueprint Medicines Corporation
    Inventors: Natasja Brooijmans, Jason D. Brubaker, Paul E. Fleming, Brian Lewis Hodous, Joseph L. Kim, Brett D. Williams, Douglas Wilson, Kevin J. Wilson, Mark Cronin
  • INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
    Publication number: 20220315585
    Abstract: Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.
    Type: Application
    Filed: May 29, 2020
    Publication date: October 6, 2022
    Inventors: Natasja Brooijmans, Jason D. Brubaker, Paul E. Fleming, Brian L. Hodous, Joseph L. Kim, Josh Waetzig, Brett Williams, Douglas Wilson, Kevin J. Wilson, Mark Cronin
  • HOLISTIC HEALTH MARKETPLACE PLATFORM
    Publication number: 20200051685
    Abstract: A system configured to: (a) receive, from a computing device, service request data including a service to be performed on behalf of a member of a carrier organization; (b) receive bid data from one or more supplier devices based on the service; (c) provide the bid data to an agent device; (d) receive winning bid data from the agent device based on the bid data; (e) transmit an electronic notification to a winning supplier device associated with a winning supplier according to the winning bid data; (f) receive a first confirmation from the winning supplier device that the service is completed; (g) receive a second confirmation from a member device of the member that the service is completed; and (h) authorize payment to a financial account associated with the winning supplier based on first confirmation and second confirmation.
    Type: Application
    Filed: August 8, 2018
    Publication date: February 13, 2020
    Inventors: Henry S. Thompson, Dharmendra R. Chokshi, Mark Cronin, Antony L. Kerz
  • Inhibitors of activin receptor-like kinase
    Patent number: 10233186
    Abstract: Described herein are compounds, such as compounds of formula (I) and pharmaceutically acceptable salts thereof, that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: March 19, 2019
    Assignee: BLUEPRINT MEDICINES CORPORATION
    Inventors: Natasja Brooijmans, Jason D. Brubaker, Mark Cronin, Paul E. Fleming, Brian L. Hodous, Joseph L. Kim, Brett Williams, Douglas Wilson, Kevin J. Wilson
  • INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
    Publication number: 20170298069
    Abstract: Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.
    Type: Application
    Filed: April 14, 2017
    Publication date: October 19, 2017
    Inventors: Natasja Brooijmans, Jason D. Brubaker, Mark Cronin, Paul E. Fleming, Brian L. Hodous, Joseph L. Kim, Josh Waetzig, Brett Williams, Douglas Wilson, Kevin J. Wilson
  • 2-QUINOLINONE AND 2-QUINOXALINONE-DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS
    Publication number: 20120270864
    Abstract: The present invention relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, to their use in the treatment of bacterial infections, and to their methods of preparation.
    Type: Application
    Filed: May 18, 2012
    Publication date: October 25, 2012
    Inventors: Andrew Aydon Godfrey, Janelle Comita-Prevoir, Mark Cronin, Bolin Geng, Folkert Reck
  • [4-( 1-AMINO-ETHYL) - CYCLOHEXYL ] - METHYL - AMINES AS ANTIBACTERIALS
    Publication number: 20110288084
    Abstract: The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof, to their use in the treatment of bacterial infections, and to their methods of preparation.
    Type: Application
    Filed: November 13, 2009
    Publication date: November 24, 2011
    Applicant: ASTRAZENECA AB
    Inventors: Mark Cronin, Bolin Geng, Folkert Reck
  • 2-QUINOLINONE AND 2-QUINOXALINONE-DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS
    Publication number: 20100144717
    Abstract: The present invention relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, to their use in the treatment of bacterial infections, and to their methods of preparation.
    Type: Application
    Filed: December 15, 2006
    Publication date: June 10, 2010
    Inventors: Janelle Comita-Prevoir, Mark Cronin, Bolin Geng, Andrew Aydon Godfrey, Folkert Reck